Probable transient antiphospholipid syndrome
Abstract
The event of at least one of the following two clinical findings (either vascular thrombosis or obstetric complication) and one of the following two laboratory findings (either positive lupus anticoagulant or β2-glycoprotein I IgG antibodies title or anticardiolipin IgM antibodies increase) in two different measurements, set the diagnosis of antiphospholipid syndrome. Fetal demise is defined the unlucky situation that happens after 34 weeks of gestation age, with neither clear laboratory findings nor reasons. Interest is presented when a clinical finding is combined with an informal laboratory finding.
References
Carbone, J., Gallego, A. et al., 2009: Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome. J Rheumatol. 36(6), 1217-25.
Clark, C.A., Spitzer, K.A., et al., 2001: The spectrum of the antiphospholipid syndrome: A matter of perspective. J. Rheumatol. 28, 1939-1941.
Clark, D.A, 2009: Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss. Am J Reprod Immunol. 61(1), 75-84.
Dong, A.M., Yin, HF., et al., 2009: Spontaneous pregnancy in a patient with lymphocytic hypophysitis. Beijing Da Xue Xue Bao. Apr 18:41(2), 242-4
Farquharson, R.G., Quenby, S., et al., 2002: Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment. Obstet. Gynecol. 100, 408-413.
Fraccaroli, L, Alfieri, J., et al., 2009: A potential tolerogenic immune mechanism in a trophoblast cell line through the activation of chemokine induced T cell death and regulatory T cell modulation. Hum Reprod, 24(1), 166-75.
Grammatikakis, I., Evaggelinakis, N., et al., 2009: Antiphospholipid syndrome and gestation: Diagnosis and treatment. Hell. J. Gyn & Obst. Apr – Jun; 8(2), 109-117.
Hacker, F.N., Moore, J.G., 1998: Essentials of Obstetrics and Gynecology. 3rd edition, W.B. Saunders Co, Philadelphia, p. 25.
Hanzlikova, J., Ulcova-Gallova, Z., et al., 2009: TH1-TH2 response and the atopy risk in patients with reproduction failure. Am J Reprod Immunol. 61(3), 213-20.
Iatrakis, G., 2004: Book of obstetrics, DESMOS Publications, Athens, p. 579.
Karakantza, M., Theodorou, G.L., et al, 2004: Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome. Ann Hematol. 83(11), 704-11.
Kim, J., Smith, K.J., et al, 2004: Delayed cutaneous reactions to heparin in antiphospholipid syndrome during pregnancy. Int J Dermatol. 43(4), 252 60.
King, K., Smith, S., et al, 2009: Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage. Hum Reprod. 61(1), 75-84.
Levine, J. S., Rauch, J., et al, 2002: Antiphospholipid syndrome. N. Engl. J. Med. 346, 752-763.
Lima, F., Khamashta, M.A., et al, 1996: A study of sixty pregnancies in parents with the antiphospholipid syndrome. Clin. Exp. Rheumatol. 14, 131-136.
Quenby, S., Nik, H., et al, 2009: Uterine natural killer cells and angiogenesis in recurrent reproductive failure. Hum Reprod. 24(1), 45-54.
Rand, J.H., Wu, S., et al, 1997: Pregnancy loss in the antiphospholipid antibody syndrome -a possible thrombogenic mechanism. N. Engl. J. Med. 337, 154-160
Saito, S., Shima, T, et al, 2007: What is the role of regulatory T cells in the success of implantation and early pregnancy? J Assist Reprod Genet. 24(9), 379-86.
Tsompos, C., Liakopoulou, E., et al, 2003: Antiphospholipid syndrome and hereditary thrombophilia. Journal of Reproductive Immunology. April; 58 (2), 174
Tsompos, C., 2011: Lymphocytosis in gestation. Case report. Subjects of Obstetrics Gynecology. October – December; 25 (4), 230 -234.
Wang, Q, Li, T.C., et al, 2008: Reappraisal of peripheral NK cells in women with recurrent miscarriage. Reprod Biomed. 17(6), 814-9.
Xia, X.Y., Yang, B., Xiong, T., et al, 2008: Evaluation of CD4+ CD25+ regulatory T cells in the peripheral blood of recurrent spontaneous abortion patients. Zhonghua Nan Ke Xue. 14(12), 1106-8.